Miochol-E (Acetylcholine Chloride)

Miochol‑E acts on the muscarinic receptors of the iris to produce controlled pupil constriction, useful in several ophthalmic conditions.

• Induction of miosis during ocular surgery: provides rapid, reversible pupil constriction to improve surgical exposure.
• Management of acute angle‑closure glaucoma: lowers intraocular pressure by increasing aqueous outflow.
• Adjunct in iridectomy procedures: assists in creating a clear surgical field by maintaining a constricted pupil.

• Acetylcholine Chloride directly stimulates muscarinic (M3) receptors on the iris sphincter muscle, causing contraction of the sphincter and resulting in pupil constriction (miosis). The same cholinergic activation enhances trabecular meshwork contractility, promoting aqueous humor drainage and reducing intraocular pressure.

Miochol‑E may cause ocular and systemic reactions after administration.

Common Side Effects

• Blurred vision: transient loss of visual clarity.
• Eye pain or discomfort: mild irritation at the site of instillation.
• Headache: occasional mild headache following pupil constriction.
• Increased lacrimation: watery eyes due to cholinergic stimulation.
• Photophobia: heightened sensitivity to light.
• Brow ache: mild muscular discomfort around the eyebrow.

Serious or Rare Side Effects

• Severe ocular inflammation: uveitis or iritis requiring immediate attention.
• Corneal ulceration: rare but serious corneal injury.
• Systemic cholinergic effects: bradycardia, hypotension, bronchospasm.
• Allergic reactions: rash, itching, or anaphylaxis.
• Persistent miosis: prolonged pupil constriction beyond expected duration.

Before using Miochol‑E, clinicians should evaluate patient‑specific factors and monitor for adverse events.

• Assess intraocular pressure: ensure baseline pressure is appropriate before instillation.
• Hypersensitivity: avoid in patients with known allergy to acetylcholine or formulation excipients.
• Respiratory disease: use with caution in asthma or COPD due to bronchospasm risk.
• Cardiovascular status: monitor heart rate and blood pressure in patients on beta‑blockers or with bradyarrhythmias.
• Systemic cholinergic drugs: watch for additive effects when combined with other cholinergic agents.
• Store at room temperature: keep in original container, protect from light and moisture.

Acetylcholine Chloride can interact with other medications that affect cholinergic pathways or ocular physiology.

Major Interactions (Avoid)

• Systemic anticholinergics (e.g., atropine): antagonize miotic effect.
• Beta‑blocker eye drops: may exacerbate bradycardia when absorbed systemically.
• Systemic cholinesterase inhibitors: increase risk of excessive cholinergic stimulation.

Moderate Interactions (Monitor Closely)

• Topical prostaglandin analogs: may reduce miotic efficacy.
• Systemic cholinergic drugs: monitor for additive ocular or systemic effects.
• Intraoperative anesthetic agents: may potentiate ocular responses and require dose adjustment.